Pheno-genotyping of verotoxin 2 (VT2)-producing Escherichia coli causing haemorrhagic colitis and haemolytic uraemic syndrome by direct analysis of patients' stools.
暂无分享,去创建一个
[1] J. Heesemann,et al. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. , 1994, Journal of medical microbiology.
[2] A. Edefonti,et al. Communitywide Outbreak of Hemolytic-Uremic Syndrome Associated with Non-O157 Verocytotoxin-Producing Escherichia coli , 1994 .
[3] B. Rowe,et al. Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157 , 1993, Journal of clinical microbiology.
[4] B. Murray,et al. Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome , 1992, Journal of clinical microbiology.
[5] A. Caprioli,et al. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group. , 1992, The Journal of infectious diseases.
[6] Jasper Hii,et al. Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1 , 1991, Journal of clinical microbiology.
[7] H. Karch,et al. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. , 1991, The Journal of pediatrics.
[8] M. McKee,et al. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 , 1991, Infection and immunity.
[9] R. Tauxe,et al. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.
[10] H R Smith,et al. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. , 1990, Archives of disease in childhood.
[11] J. Samuel,et al. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants , 1990, Infection and immunity.
[12] S. Ostroff,et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.
[13] H. Karch,et al. Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli , 1989, Journal of clinical microbiology.
[14] M. Karmali,et al. Infection by verocytotoxin-producing Escherichia coli , 1989, Clinical Microbiology Reviews.
[15] R. Holmes,et al. Shiga and Shiga-like toxins. , 1987, Microbiological reviews.
[16] R. Holmes,et al. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities , 1986, Infection and immunity.